3,227 results on '"Cohen, Stanley"'
Search Results
2. Government Responses to Human Rights Reports: Claims, Denials, and Counterclaims
3. Correction: Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis
4. The Effect of Discontinuing Denosumab in Patients With Rheumatoid Arthritis Treated With Glucocorticoids
5. Capsule Endoscopy in Pediatric Inflammatory Bowel Disease
6. Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs
7. Artificial Intelligence in Pathology
8. Commentary on Cohen et al.: Role of Clinical Factors in Precision Medicine Test to Predict Nonresponse to TNFi Therapies in Rheumatoid Arthritis
9. Mucosal Inflammatory and Wound Healing Gene Programs Reveal Targets for Stricturing Behavior in Pediatric Crohn's Disease.
10. Janus kinase inhibitors: efficacy and safety
11. Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial
12. A Phase 1, randomized, double-blind, placebo-controlled, single- and multiple-dose escalation study to evaluate the safety and pharmacokinetics/pharmacodynamics of PF-06835375, a C-X-C chemokine receptor type 5 directed antibody, in patients with systemic lupus erythematosus or rheumatoid arthritis
13. SUSTAINED CLINICAL EFFECTS AFTER A SINGLE INTRAARTICULAR INJECTION OF PCRX201 FOR MODERATE-TO-SEVERE OSTEOARTHRITIS OF THE KNEE
14. Oral surveillance and JAK inhibitor safety: the theory of relativity
15. Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel)
16. Age-of-diagnosis dependent ileal immune intensification and reduced alpha-defensin in older versus younger pediatric Crohn Disease patients despite already established dysbiosis
17. Impact of Methotrexate Discontinuation, Interruption, or Persistence in US Patients with Rheumatoid Arthritis Initiating Tofacitinib + Oral Methotrexate Combination
18. Safety and efficacy of elsubrutinib or upadacitinib alone or in combination (ABBV-599) in patients with rheumatoid arthritis and inadequate response or intolerance to biological therapies: a multicentre, double-blind, randomised, controlled, phase 2 trial
19. Benefit–Risk Analysis of Upadacitinib Compared with Adalimumab in the Treatment of Patients with Moderate-to-Severe Rheumatoid Arthritis
20. A Review of the Totality of Evidence for the Development and Approval of ABP 710 (AVSOLA), an Infliximab Biosimilar
21. Outcomes in Adult Inflammatory Bowel Disease Clinical Trials: Assessment of Similarity Among Participants with Adolescent-onset and Adult-onset Disease.
22. Ustekinumab in paediatric patients with moderately to severely active Crohn's disease: UniStar study long‐term extension results.
23. A Treat-to-Target Strategy Guided by Pan-Enteric Evaluation in Children With Crohn's Disease Improves Outcomes at 2 Years.
24. Increasing Prevalence and Racial Disparity of Alcohol-Related Gastrointestinal and Liver Disease During the COVID-19 Pandemic: A Population-Based National Study
25. Long ncRNA Landscape in the Ileum of Treatment-Naive Early-Onset Crohn Disease.
26. What Advice Current Pathology Chairs Seek From Former Chairs.
27. What Advice Current Pathology Chairs Seek From Former Chairs.
28. Chronic Hepatitis C
29. Criminology
30. Dealing with Multi-Dimensional Data and the Burden of Annotation: Easing the Burden of Annotation
31. A Response to: Letter to the Editor Regarding A Molecular Signature Response Classifier to Predict Inadequate Response to Tumor Necrosis Factor-α Inhibitors: The NETWORK-004 Prospective Observational Study
32. A Molecular Signature Response Classifier to Predict Inadequate Response to Tumor Necrosis Factor-α Inhibitors: The NETWORK-004 Prospective Observational Study
33. Construction of Biologically Functional Bacterial Plasmids In Vitro
34. Criminology
35. Clinical Characteristics, Hospitalization, and Mortality Rates of Coronavirus Disease 2019 Among Liver Transplant Patients in the United States: A Multicenter Research Network Study
36. Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study
37. Upadacitinib in Rheumatoid Arthritis: A Benefit–Risk Assessment Across a Phase III Program
38. Eight Weeks of Treatment With Glecaprevir/Pibrentasvir Is Safe and Efficacious in an Integrated Analysis of Treatment-Naïve Patients With Hepatitis C Virus Infection
39. Real-World Evidence to Contextualize Clinical Trial Results and Inform Regulatory Decisions: Tofacitinib Modified-Release Once-Daily vs Immediate-Release Twice-Daily for Rheumatoid Arthritis
40. Drug-Induced Liver Injury from Statins
41. Detecting Microbial Dysbiosis Associated with Pediatric Crohn Disease Despite the High Variability of the Gut Microbiota
42. Correction: Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis
43. S1412 Reconsidering the Diagnostic Yield of Routine Esophagogastroduodenoscopy Prior to Transesophageal Echocardiography in Patients With Cirrhosis
44. Biosimilars for Rheumatoid Arthritis: Riding the 2023 Wave [Podcast]
45. S1472 Risk of Cardiovascular Disease in Primary Sclerosing Cholangitis
46. Efficacy and safety results from a randomized double-blind study comparing proposed biosimilar ABP 798 with rituximab reference product in subjects with moderate-to-severe rheumatoid arthritis
47. The basics of machine learning: strategies and techniques
48. Contributors
49. The evolution of machine learning: past, present, and future
50. Complexity in the use of artificial intelligence in anatomic pathology
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.